NDC 50090-0182-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0182
- Requested NDC
- 50090-0182-01
- Package NDCs from labels
- 50090-0182-4, 50090-0182-2, 50090-0182-0, 50090-0182-5, 50090-0182-8, 50090-0182-1, 50090-0182-3, 50090-0182-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-10-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - A-S Medication Solutions | A-S Medication Solutions | 2025-10-16 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-0182-1 | 2023-11-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-1 | 2023-11-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-3 | 2023-11-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-3 | 2023-11-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-4 | 2023-11-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-4 | 2023-11-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-5 | 2023-11-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-5 | 2023-11-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-1 | 2023-01-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-1 | 2023-01-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-3 | 2023-01-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-3 | 2023-01-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-4 | 2023-01-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-4 | 2023-01-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-5 | 2023-01-30 | Methocarbamol Tablets USP Rx Only |
| 50090-0182-5 | 2023-01-30 | Methocarbamol Tablets USP Rx Only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0182-0 | Methocarbamol | 40 in 1 BOTTLE | TABLET | 40 | 18 | |
| 50090-0182-1 | Methocarbamol | 20 in 1 BOTTLE | TABLET | 20 | 18 | |
| 50090-0182-2 | Methocarbamol | 80 in 1 BOTTLE | TABLET | 80 | 18 | |
| 50090-0182-3 | Methocarbamol | 60 in 1 BOTTLE | TABLET | 60 | 18 | |
| 50090-0182-4 | Methocarbamol | 30 in 1 BOTTLE | TABLET | 30 | 18 | |
| 50090-0182-5 | Methocarbamol | 14 in 1 BOTTLE | TABLET | 14 | 18 | |
| 50090-0182-8 | Methocarbamol | 56 in 1 BOTTLE | TABLET | 56 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0182 | METHOCARBAMOL TABLET [A-S MEDICATION SOLUTIONS] | 15 | Current NDC, Legacy NDC, 7 package rows | 20231130_9aed8304-fa4e-49d6-bd81-fcb3e4cc6173.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0182-1 | EA - Each | 50090-0182 | 4c42f303-6d85-4194-8ffd-0920eed7d8b3 | 1 | 2018-08-13 |
| 50090-0182-3 | EA - Each | 50090-0182 | 2dc94b35-5a73-4c2f-bf5a-18984cdb56f7 | 1 | 2018-08-13 |
| 50090-0182-4 | EA - Each | 50090-0182 | 5d0ed9c3-ee8e-4e97-81f7-2c38671ed301 | 1 | 2018-08-13 |
| 50090-0182-5 | EA - Each | 50090-0182 | c557bb56-b132-4567-b203-00ea6c1966d7 | 1 | 2021-05-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | adb49cb7-8900-44dc-add0-22e2cd8235ac | 2026-07-29 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 0deb5368-ffdc-40fc-a97c-ba89b7a97e50 | 2026-07-21 | Warnings, Adverse reactions | 197943 125OD7737X |
| Prid | ICHTHAMMOL, CALCIUM SULFIDE, CALENDULA OFFICINALIS FLOWERING TOP, ARNICA MONTANA, ECHINACEA ANGUSTIFOLIA, SILICON DIOXIDE, SULFUR | Hyland's Inc. | 49689eeb-7790-07f1-e063-6294a90a2df2 | 2026-07-16 | Warnings | ETJ7Z6XBU4 |
| Leg Cramps PM | OYSTER SHELL CALCIUM CARBONATE, CRUDE, CAUSTICUM, MATRICARIA RECUTITA, CINCHONA OFFICINALIS BARK, COPPER, LYCOPODIUM CLAVATUM SPORE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF, SILICON DIOXIDE, AND SULFUR | Hyland's Inc. | b0574a7e-88fa-417e-b6d5-60ced59eba47 | 2026-07-15 | Warnings | ETJ7Z6XBU4 |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 52b20439-6bf4-435e-817a-c3b3fc70846a | 2026-07-10 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 37767123-8b72-4e1f-b00d-ff3305e9923f | 2026-07-10 | Warnings, Adverse reactions | 197944 125OD7737X |
| Jacksons Cell Salts SILICA 12X 12 | SILICEA | Zettl Health Inc. | 5647dafc-1fff-6a25-e063-6294a90a8b4f | 2026-07-10 | ETJ7Z6XBU4 | |
| Methocarbamol | METHOCARBAMOL TABLETS | Unit Dose Solutions, Inc. | 561ae476-9e1f-038a-e063-6394a90aa5c7 | 2026-07-08 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules Pharmaceuticals Inc. | 6f0d3966-962d-fa7c-e053-2a91aa0a8e3c | 2026-07-07 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Bryant Ranch Prepack | 65c460f6-6470-41ff-abb4-d9d54ecc52f7 | 2026-07-06 | Warnings, Adverse reactions | 197944 125OD7737X |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | ETJ7Z6XBU4 |
| Bambusa Stannum | BAMBUSA STANNUM | Uriel Pharmacy Inc. | a0d4d0ac-e2d2-4381-8f93-e41719521859 | 2026-06-30 | Warnings | ETJ7Z6XBU4 |
| Methocarbamol | METHOCARBAMOL | Unit Dose Solutions, Inc. | 5539d4f6-1192-2770-e063-6394a90a1e50 | 2026-06-27 | Warnings, Adverse reactions | ANDA090200 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 9617e2b0-4255-4542-95ca-9ee1818ca450 | 2026-06-26 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | HAWAII REPACK, INC. | 8643032a-c491-4ae4-ac46-5e0c4c79dc5b | 2026-06-26 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | St. Mary's Medical Park Pharmacy | 7d4dd78a-f902-6ff2-e053-2991aa0ac7d7 | 2026-06-26 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | cfdc0d68-00ad-44d6-b932-819cc3d5d60e | 2026-06-26 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | b81a8e64-ae41-409b-94a6-b36cb50bc25d | 2026-06-26 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | HAWAII REPACK, INC. | c4744824-4c74-411d-aa8e-c63ee9d89913 | 2026-06-25 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Preferred Pharmaceuticals Inc. | 43f83b87-e169-46fe-98bd-6af373595bd3 | 2026-06-23 | Warnings, Adverse reactions | 197944 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.